Last price
$267.60
Etch & deposition; essential for advanced chip manufacturing at scale.
Live quote sourced from Yahoo Finance. Prices cited in narrative below reflect the original memo date and may be stale.
Lam manufactures etch and deposition equipment for semiconductor wafers. These tools are essential for advanced node production (5nm, 3nm, 2nm) and are critical bottlenecks in foundry capacity. As AI demand drives chip manufacturing, Lam's tools enable production. Like KLAC, Lam is a high-enabler for autopilot-enabling chips.
LRCX is the co-leader with AMAT in foundry etch and deposition equipment. As advanced nodes scale and process complexity increases, LRCX tools become essential for 3D pattern control, high-aspect-ratio etch, and advanced deposition. The company is a pure beneficiary of the AI capex wave: more foundry capex → more etch/deposition tool orders → more LRCX revenue.
3D NAND (stacking memory layers), chiplet packaging (bonding dies), and extreme aspect-ratio patterning at 3nm/2nm all require cutting-edge etch and deposition equipment. LRCX is a primary supplier for these processes. As foundry capex accelerates (driven by AI demand), LRCX captures disproportionate share of etch/deposition budgets. The companys plasma etch tools are differentiated, with switching costs and high switching costs.
| Process | LRCX Position | Importance for Advanced Nodes | Competition |
|---|---|---|---|
| Plasma etch (critical patterns) | Market leader, 50%+ share | Core (extreme aspect ratios at 3nm) | AMAT, Tokyo Electron |
| Atomic-layer deposition (ALD) | Strong position | Critical for 2nm and smaller | AMAT, Tokyo Electron |
| High-aspect-ratio etch (HARE) | Leader | Essential for 3D NAND stacking | AMAT competition rising |
| Selective deposition | Growing share | New process node requirement | Early-stage competition |
| Advanced packaging (chiplet bonding) | Expanding segment | Moderate importance | Emerging competition |
LRCX is the market leader in plasma etch with 50%+ share. Foundries cannot transition to advanced nodes without LRCX tools. Demand grows with every node transition.
HARE is used in 3D NAND and advanced packaging (chiplets). This segment is growing 20%+ CAGR and is less commoditized than standard etch.
Every major node transition (3nm, 2nm) requires new LRCX equipment. As AI demand drives advanced-node scaling, LRCX captures cyclical refresh orders.
Newer process nodes require atomic-precision deposition (growing margins to 50%+). LRCX is gaining share in this emerging market.
LRCX revenue swings 30%+ year-to-year with capex. If hyperscaler capex softens, LRCX is directly impacted.
AMATs breadth (deposition, etch, inspection) gives it scale advantages. LRCXs pure-play etch position is under pressure as deposition becomes more important at advanced nodes.
TSMC and Samsung are 70%+ of revenues. Any shift in their capex priorities directly impacts LRCX. Diversification to Intel or new foundries is slow.
China export controls reduce addressable market. Foundry capex in mainland China is off-limits for advanced etch tools.
LRCX is a core beneficiary of foundry capex driven by AI demand. The company is the leader in plasma etch, a non-negotiable tool for advanced nodes. However, LRCX is smaller in scale than ASML and more exposed to competition from AMAT. The verdict is Buy with execution risk: if foundry capex accelerates as the thesis predicts, LRCX is a 20%+ growth compounder with 50%+ margins. But if capex cycles trough, or AMAT gains etch share, LRCX compresses. Current backlog and 18–25% guidance suggest the upside scenario is playing out.
Lam is essential for advanced chip manufacturing; strong business, but indirect thesis benefit.